Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast cancer progressing after anthracycline and taxane

被引：0
|
作者：
Ozdemir, Nuriye Yildirim [1 ]
Abali, Huseyin [1 ]
Oksuzoglu, Berna [1 ]
Budakoglu, Burcin [1 ]
Uncu, Dogan [1 ]
Guler, Tunc [1 ]
Zengin, Nurullah [1 ]
Hastanesi, Ankara Numune [1 ]
机构：
[1] Ankara Numune Hastanesi Med Onkol Klin, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Tao Wang
    Shaohua Zhang
    Min Zeng
    Xinyou Lu
    Ge Shen
    Shikai Wu
    Santai Song
    Zefei Jiang
    Medical Oncology, 2012, 29 : 56 - 61
  • [22] Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Wang, Tao
    Zhang, Shaohua
    Zeng, Min
    Lu, Xinyou
    Shen, Ge
    Wu, Shikai
    Song, Santai
    Jiang, Zefei
    MEDICAL ONCOLOGY, 2012, 29 (01) : 56 - 61
  • [23] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Park, Ji Soo
    Jeung, Hei-Cheul
    Rha, Sun Young
    Ahn, Joong Bae
    Kang, Beodeul
    Chon, Hong Jae
    Hong, Min Hee
    Lim, Seungtaek
    Yang, Woo Ick
    Nam, Chung Mo
    Chung, Hyun Cheol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 799 - 808
  • [24] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Ji Soo Park
    Hei-Cheul Jeung
    Sun Young Rha
    Joong Bae Ahn
    Beodeul Kang
    Hong Jae Chon
    Min Hee Hong
    Seungtaek Lim
    Woo Ick Yang
    Chung Mo Nam
    Hyun Cheol Chung
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 799 - 808
  • [25] Salvage capecitabine-leucovorine-vinorelbine combination chemotherapy in both anthracycline and taxane resistant metastatic breast cancer
    Stamatovic, L
    Jelic, S
    Susnjar, S
    Vasovic, S
    Nikolic-Tomasevic, Z
    Neskovic-Konstantinovic, Z
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S74
  • [26] Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab after Anthracycline, Taxane, and Capecitabine
    Tanabe, Masahiko
    CASE REPORTS IN ONCOLOGY, 2016, 9 (02): : 422 - 426
  • [27] Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer
    A Urruticoechea
    C D Archer
    L A Assersohn
    R K Gregory
    M Verrill
    R Mendes
    G Walsh
    I E Smith
    S R D Johnston
    British Journal of Cancer, 2005, 92 : 475 - 479
  • [28] Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer
    Urruticoechea, A
    Archer, CD
    Assersohn, LA
    Gregory, RK
    Verrill, M
    Mendes, R
    Walsh, G
    Smith, IE
    Johnston, SRD
    BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 475 - 479
  • [29] Cisplatin, epirubicin, capecitabine, and gemcitabine (PEXG) as first-line treatment in metastatic or unresectable pancreatic cancer: Active and well tolerated?
    Rivalland, Gareth
    Lawrence, Benjamin James
    Mesnage, Soizick Jeanne Lynette
    Reeve, Jane
    Findlay, Michael P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer
    Wist, EA
    Sommer, HH
    Ostenstad, B
    Risberg, T
    Bremnes, Y
    Mjaaland, I
    ACTA ONCOLOGICA, 2004, 43 (02) : 186 - 189
12345